Ann: Mesoblast Completes Placement and Entitlement Offer, page-45

It seems obvious (at a minimum, extremely likely) that all USA partnership deals are conditional on FDA approval.

That is a very poor reflection on the BoDs. Like, the pits.

Rose buying is a diversion. Forget who purchased the shares. It’s a further massive dilution at 30c a share and MSB still carries ALL the risk on ALL the trials.

Why has SI not issued a statement that partnerships are conditional on FDA approval??? How has that question not been asked of him, enabling a response???

This is poor from the BoDs. And they know it. The company is being run like a hobby farm and no one has responsibility to inform shareholders.


Stop celebrating what this current BoDs do. I suggest SHs don’t get too attached to any of them. These aren’t acts of celebration - they are acts of desperation.

Let’s celebrate another Board member - lucky Phil. He bought in at $2.30 a share and recently sold down for tax reasons. Yay! Oh but Rose is different? Really? Was Fred Grossman different also?

This announcement is telegraphing that FDA approval is not going to be soon. If it was thought to be soon then the overhang would not of been done at 30c.

Highly likely this goes back to 30c. Instos selling for profit to excited retail all the way.